scarlet therapeutics limited
scarlet therapeutics limited Company Information
Company Number
13536278
Website
-Registered Address
science creates old market, midland road, bristol, somerset, BS2 0JZ
Industry
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
April 2025
Group Structure
View All
Shareholders
kcp nominees ltd 24.3%
university of bristol 17.6%
View Allscarlet therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of SCARLET THERAPEUTICS LIMITED at £1.8m based on a Turnover of £1.7m and 1.06x industry multiple (adjusted for size and gross margin).
scarlet therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of SCARLET THERAPEUTICS LIMITED at £7.1m based on an EBITDA of £1.6m and a 4.32x industry multiple (adjusted for size and gross margin).
scarlet therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of SCARLET THERAPEUTICS LIMITED at £2.7m based on Net Assets of £1.2m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Scarlet Therapeutics Limited Overview
Scarlet Therapeutics Limited is a live company located in bristol, BS2 0JZ with a Companies House number of 13536278. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2021, it's largest shareholder is kcp nominees ltd with a 24.3% stake. Scarlet Therapeutics Limited is a startup, small sized company, Pomanda has estimated its turnover at £1.7m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Scarlet Therapeutics Limited Health Check
Pomanda's financial health check has awarded Scarlet Therapeutics Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £1.7m, make it smaller than the average company (£3.6m)
- Scarlet Therapeutics Limited
£3.6m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Scarlet Therapeutics Limited
- - Industry AVG
Production
with a gross margin of 26.2%, this company has a higher cost of product (54.4%)
- Scarlet Therapeutics Limited
54.4% - Industry AVG
Profitability
an operating margin of 98.3% make it more profitable than the average company (-1.1%)
- Scarlet Therapeutics Limited
-1.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (42)
1 - Scarlet Therapeutics Limited
42 - Industry AVG
Pay Structure
on an average salary of £74.9k, the company has an equivalent pay structure (£74.9k)
- Scarlet Therapeutics Limited
£74.9k - Industry AVG
Efficiency
resulting in sales per employee of £1.7m, this is more efficient (£125.8k)
- Scarlet Therapeutics Limited
£125.8k - Industry AVG
Debtor Days
it gets paid by customers after 287 days, this is later than average (53 days)
- Scarlet Therapeutics Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is quicker than average (62 days)
- Scarlet Therapeutics Limited
62 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Scarlet Therapeutics Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Scarlet Therapeutics Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 14.7%, this is a lower level of debt than the average (52.7%)
14.7% - Scarlet Therapeutics Limited
52.7% - Industry AVG
SCARLET THERAPEUTICS LIMITED financials
Scarlet Therapeutics Limited's latest turnover from July 2023 is estimated at £1.7 million and the company has net assets of £1.2 million. According to their latest financial statements, Scarlet Therapeutics Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | |
|---|---|---|
| Tangible Assets | 108,513 | 0 |
| Intangible Assets | 0 | 0 |
| Investments & Other | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 |
| Total Fixed Assets | 108,513 | 0 |
| Stock & work in progress | 0 | 0 |
| Trade Debtors | 1,319,335 | 3,100 |
| Group Debtors | 0 | 0 |
| Misc Debtors | 2,397 | 0 |
| Cash | 0 | 0 |
| misc current assets | 0 | 0 |
| total current assets | 1,321,732 | 3,100 |
| total assets | 1,430,245 | 3,100 |
| Bank overdraft | 0 | 0 |
| Bank loan | 0 | 0 |
| Trade Creditors | 188,355 | 18,000 |
| Group/Directors Accounts | 0 | 0 |
| other short term finances | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| other current liabilities | 0 | 0 |
| total current liabilities | 188,355 | 18,000 |
| loans | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| Accruals and Deferred Income | 22,407 | 0 |
| other liabilities | 0 | 0 |
| provisions | 0 | 0 |
| total long term liabilities | 22,407 | 0 |
| total liabilities | 210,762 | 18,000 |
| net assets | 1,219,483 | -14,900 |
| total shareholders funds | 1,219,483 | -14,900 |
| Jul 2023 | Jul 2022 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | 0 | |
| Amortisation | 0 | |
| Tax | ||
| Stock | 0 | 0 |
| Debtors | 1,318,632 | 3,100 |
| Creditors | 170,355 | 18,000 |
| Accruals and Deferred Income | 22,407 | 0 |
| Deferred Taxes & Provisions | 0 | 0 |
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | 0 | 0 |
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | 0 | 0 |
| Group/Directors Accounts | 0 | 0 |
| Other Short Term Loans | 0 | 0 |
| Long term loans | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 |
| other long term liabilities | 0 | 0 |
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 0 | 0 |
| overdraft | 0 | 0 |
| change in cash | 0 | 0 |
scarlet therapeutics limited Credit Report and Business Information
Scarlet Therapeutics Limited Competitor Analysis
Perform a competitor analysis for scarlet therapeutics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in BS2 area or any other competitors across 12 key performance metrics.
scarlet therapeutics limited Ownership
SCARLET THERAPEUTICS LIMITED group structure
Scarlet Therapeutics Limited has no subsidiary companies.
Ultimate parent company
SCARLET THERAPEUTICS LIMITED
13536278
scarlet therapeutics limited directors
Scarlet Therapeutics Limited currently has 5 directors. The longest serving directors include Professor Ashley Toye (Jul 2021) and Professor Janet Frayne (Aug 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Ashley Toye | England | 51 years | Jul 2021 | - | Director |
| Professor Janet Frayne | England | 61 years | Aug 2022 | - | Director |
| Dr Harry Destecroix | England | 37 years | Aug 2022 | - | Director |
| Mr Andrew Wilson | 51 years | Aug 2022 | - | Director | |
| Dr Alistair Irvine | England | 55 years | Aug 2022 | - | Director |
P&L
July 2023turnover
1.7m
+11675%
operating profit
1.6m
0%
gross margin
26.3%
-17.56%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
1.2m
-82.84%
total assets
1.4m
+460.37%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
scarlet therapeutics limited company details
company number
13536278
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
July 2021
age
3
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
July 2023
address
science creates old market, midland road, bristol, somerset, BS2 0JZ
accountant
-
auditor
-
scarlet therapeutics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to scarlet therapeutics limited.
scarlet therapeutics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
